81 research outputs found
Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients
<p>Abstract</p> <p>Background</p> <p>Endoglin is involved in the regulation of endothelial function, but there are no studies concerning its relation with hypertension- and diabetes-associated pathologies. Thus, we studied the relationship between plasma levels of soluble endoglin and cardiovascular alterations associated with hypertension and diabetes.</p> <p>Methods</p> <p>We analyzed 288 patients: 64 with type 2 diabetes, 159 with hypertension and 65 healthy patients. We assessed the relationship of soluble endoglin plasma levels measured by enzyme-linked immunosorbent assay with basal glycemia, glycosylated hemoglobin, blood pressure, endothelial dysfunction (assessed by pressure wave velocity), hypertensive retinopathy (by Keith-Wagener classification), left ventricular hypertrophy (by Cornell and Sokolow indexes), cardiovascular risk and target organ (heart, vascular, kidney) damage.</p> <p>Results</p> <p>There are significant correlations between endoglin and glycemia, systolic blood pressure, pulse pressure, pressure wave velocity and electrocardiographically assessed left ventricular hypertrophy. Endoglin levels were significantly higher in patients with diabetes who had nondipper and extreme dipper circadian blood pressure patterns than in dipper circadian patterns, in patients with hypertension and diabetes who had riser pattern than in the other patients, and in patients with diabetes but not hypertension who had extreme dipper pattern than in dipper, nondipper and riser groups. There was also a significant correlation between plasma-soluble endoglin and lower levels of systolic night-day ratio. Higher endoglin levels were found in patients with diabetes who had retinopathy, in patients with diabetes who had a high probability of 10-year cardiovascular risk, and in patients with diabetes and hypertension who had three or more damaged target organs (heart, vessels, kidney) than in those with no organs affected.</p> <p>Conclusions</p> <p>This study shows that endoglin is an indicator of hypertension- and diabetes-associated vascular pathologies as endothelial dysfunction and cardiovascular damage.</p
Effectiveness of a multifactorial intervention in increasing adherence to the mediterranean diet among patients with diabetes mellitus type 2: a controlled and randomized study (EMID Study)
The Mediterranean diet (MD) is recognized as one of the healthiest dietary patterns and has
benefits such as improving glycaemic control among patients with type 2 diabetes (T2DM). Our aim is
to assess the effectiveness of a multifactorial intervention to improve adherence to theMD, diet quality
and biomedical parameters. The EMID study is a randomized and controlled clinical trial with two
parallel groups and a 12-month follow-up period. The study included 204 subjects between 25–70 years
with T2DM. The participants were randomized into intervention group (IG) and control group (CG).
Both groups received brief advice about healthy eating and physical activity. The IG participants
additionally took part in a food workshop, five walks and received a smartphone application for three
months. The population studied had a mean age of 60.6 years. At the 3-month follow-up visit, there
were improvements in adherence to the MD and diet quality of 2.2 and 2.5 points, compared to the
baseline visit, respectively, in favour of the IG. This tendency of the improvement was maintained,
in favour of the IG, at the 12-month follow-up visit. In conclusion, the multifactorial intervention
performed could improve adherence to the MD and diet quality among patients with T2DM.Regional Health Management through the 2016
grants to carry out research projects in biomedicine, health management and socio-health care (GRS 1276/B/16),
the 2016 program for the professional development of nurses in their research activity (BOCYL-D-11022016-2) and
the 2015 incentive program for nurses who have completed their residency (ORDER SAN / 360/2015). The study
was also co-financed by the Carlos III Health Institute and the European Regional Development Fund (ERDF) (RD
16/0007/0003)
Vascular and cognitive effects of cocoa-rich chocolate in postmenopausal women: a study protocol for a randomised clinical trial
Introduction The intake of polyphenols has certain health
benefits. This study will aim to assess the effect of adding
a daily amount of chocolate high in cocoa content and
polyphenols to the normal diet on blood pressure, vascular
function, cognitive performance, quality of life and body
composition in postmenopausal women.
Methods and analysis Here we plan a randomised
clinical trial with two parallel groups involving a
total of 140 women between 50 and 64 years in the
postmenopausal period, defined by amenorrhoea of at
least 12 consecutive months. The main variable will be
the change in blood pressure. Secondary variables will
be changes in vascular function, quality of life, cognitive
performance and body composition. The intervention
group will be given chocolate containing 99% cocoa, with
instructions to add 10 g daily to their normal diet for 6
months. The daily nutritional contribution of this amount
of chocolate is 59 kcal and 65.4 mg of polyphenols. There
will be no intervention in the control group. All variables
will be measured at the baseline visit and 3 and 6 months
after randomisation, except cognitive performance and
quality of life, which will only be assessed at baseline and
at 6 months. Recruitment is scheduled to begin on 1 June
2018, and the study will continue until 31 May 2019.
Ethics and dissemination This study was approved
by the Clinical Research Ethics Committee of the Health
Area of Salamanca, Spain (‘CREC of Health Area of
Salamanca’), in February 2018. A SPIRIT checklist is
available for this protocol. The clinical trial has been
registered at ClinicalTrials. gov provided by the US National
Library of Medicine, number NCT03492983. The results
will be disseminated through open access peer-reviewed
journals, conference presentations, broadcast media and a
presentation to stakeholders.Gerencia Regional de Castilla y León (GRS 1583/B/1
Relationship between target organ damage and blood pressure, retinal vessel calibre, oxidative stress and polymorphisms in VAV-2 and VAV-3 genes in patients with hypertension: a case-control study protocol (LOD- Hipertensión)
This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license.[Introduction]: Target organ damage (TOD) is associated with increased cardiovascular risk. The study objectives were to analyse the relationship of TOD to blood pressure, size of retinal arteries and veins, oxidative stress and different polymorphisms in the VAV-2 and VAV-3 genes in participants with hypertension. [Methods and analysis]: A case-control study to analyse the relationship between clinical, biochemical and genetic parameters and presence of cardiac, vascular and renal TOD in 486 patients with hypertension. Participants with TOD will be considered as cases, and those without TOD will be enrolled as controls. This will be a collaborative study conducted by the groups of Primary Care, Cardiovascular and Metabolic and Degenerative Diseases of the Instituto de Investigación Biomédica of Salamanca (IBSAL). Assessment of cardiac, renal and vascular TOD. Measurement of peripheral and central blood pressure, size of eye fundus arteries and veins, and oxidative stress, and polymorphisms in the VAV-2 and VAV-3 genes. [Ethics and dissemination]: The study will be conducted after approval is obtained from the Ethics Committee of Hospital Clínico Universitario of Salamanca. All study participants will sign an informed consent to agree to participate in the study, and another consent to agree on the genetic study, in compliance with the Declaration of Helsinki and the WHO standards for observational studies. The results of this study will allow for an understanding of the relationship of the different TODs with blood pressure, retinal artery and vein diameters, oxidative stress and polymorphisms in VAV-2 and VAV-3 genes. [Trial registration number]: Clinical Trials. gov Identifier: NCT02022618.This project has been supported by the Castilla y León Health Service (BIO/SA05/13), Carlos III Institute of Health of the Spanish Ministry of Health (RETICS RD12/0005, RedIAPP, and RD12/0021, RedinRen), and Infosalud Foundation.Peer Reviewe
Combined use of smartphone and smartband technology in the improvement of lifestyles in the adult population over 65 years: study protocol for a randomized clinical trial (EVIDENT-Age study)
Background
The increasing use of smartphones by older adults also increases their potential for improving different aspects of health in this population. Some studies have shown promising results in the improvement of cognitive performance through lifestyle modification. All this may have a broad impact on the quality of life and carrying out daily living activities. The objective of this study is to evaluate the effectiveness of combining the use of smartphone and smartband technology for 3 months with brief counseling on life habits, as opposed to providing counseling only, in increasing physical activity and improving adherence to the Mediterranean diet. Secondary objectives are to assess the effect of the intervention on body composition, quality of life, independence in daily living activities and cognitive performance.
Methods
This study is a two-arm cluster-randomized trial that will be carried out in urban health centers in Spain. We will recruit 160 people aged between 65 and 80 without cardiovascular disease or cognitive impairment (score in the Mini-mental State Examination ≥24). On a visit to their center, intervention group participants will be instructed to use a smartphone application for a period of 3 months. This application integrates information on physical activity received from a fitness bracelet and self-reported information on the patient’s daily nutritional composition. The primary outcome will be the change in the number of steps measured by accelerometer. Secondary variables will be adherence to the Mediterranean diet, sitting time, body composition, quality of life, independence in daily living activities and cognitive performance. All variables will be measured at baseline and on the assessment visit after 3 months. A telephone follow-up will be carried out at 6 months to collect self-reported data regarding physical activity and adherence to the Mediterranean diet.
Discussion
Preventive healthy aging programs should include health education with training in nutrition and lifestyles, while stressing the importance of and enhancing physical activity; the inclusion of new technologies can facilitate these goals. The EVIDENT-AGE study will incorporate a simple, accessible intervention with potential implementation in the care of older adults.This study was supported in part by grants funded by the Instituto de Salud
Carlos III, Institute of Biomedical Research of Salamanca (IBSAL)-IBY17/00003,
and the Spanish Research Network for Preventive Activities and Health
Promotion in Primary Care (REDIAPP)-RD16/0007
EVIDENT smartphone app, a new method for the dietary record: comparison with a food frequency questionnaire
Background: More alternatives are needed for recording people’s normal diet in different populations, especially adults or the
elderly, as part of the investigation into the effects of nutrition on health.
Objective: The aim of this study was to compare the estimated values of energy intake, macro- and micronutrient, and alcohol
consumption gathered using the EVIDENT II smartphone app against the data estimated with a food frequency questionnaire
(FFQ) in an adult population aged 18 to 70 years.
Methods: We included 362 individuals (mean age 52 years, SD 12; 214/362, 59.1% women) who were part of the EVIDENT
II study. The participants registered their food intake using the EVIDENT app during a period of 3 months and through an FFQ.
Both methods estimate the average nutritional composition, including energy intake, macro- and micronutrients, and alcohol.
Through the app, the values of the first week of food recording, the first month, and the entire 3-month period were estimated.
The FFQ gathers data regarding the food intake of the year before the moment of interview.
Results: The intraclass correlation for the estimation of energy intake with the FFQ and the app shows significant results, with
the highest values returned when analyzing the app’s data for the full 3-month period (.304, 95% CI 0.144-0.434; P<.001). For this period, the correlation coefficient for energy intake is .233 (P<.001). The highest value corresponds to alcohol consumption
and the lowest to the intake of polyunsaturated fatty acids (r=.676 and r=.155; P<.001), respectively. The estimation of daily
intake of energy, macronutrients, and alcohol presents higher values in the FFQ compared with the EVIDENT app data. Considering
the values recorded during the 3-month period, the FFQ for energy intake estimation (Kcal) was higher than that of the app (a
difference of 408.7, 95% CI 322.7-494.8; P<.001). The same is true for the other macronutrients, with the exception g/day of
saturated fatty acids (.4, 95% CI −1.2 to 2.0; P=.62).
Conclusions: The EVIDENT app is significantly correlated to FFQ in the estimation of energy intake, macro- and micronutrients,
and alcohol consumption. This correlation increases with longer app recording periods. The EVIDENT app can be a good
alternative for recording food intake in the context of longitudinal or intervention studies.
Trial Registration: ClinicalTrials.gov NCT02016014; http://clinicaltrials.gov/ct2/show/NCT02016014 (Archived by WebCite
at http://www.webcitation.org/760i8EL8Q).Spanish Ministry of Science and Innovation and Carlos III Health Institute/European Regional Development Fund (FIS: PI13/00618, PI13/01526, PI13/00058, PI13/01635, PI13/02528, PI12/01474; RETICS: RD12/0005, RD16/0007), Regional Health Management of Castilla and León (GRS 1191/B/15, GRS 909/B/14, GRS 770/B/13), and the Infosalud Foundatio
Glycemic markers and relation with arterial stiffness in Caucasian subjects of the MARK study
[EN]BACKGROUND:
Effect of prediabetes and normal glucose on arterial stiffness remains controversial. The primary aim of this study was to investigate the relationship of fasting plasma glucose (FPG), postprandial glucose (PG) and glycosylated haemoglobin (HbA1c) with brachial-ankle pulse wave velocity (baPWV) and cardio-ankle vascular index (CAVI) in Caucasian adults. The secondary aim was to analyse this relationship by glycaemic status.
METHODS:
Cross-sectional study. Setting: Primary care. Participants: 2,233 subjects, 35-74 years. Measures: FPG (mg/dL) and HbA1c (%) of all subjects were measured using standard automated enzymatic methods. PG (mg/dL) was self-measured at home two hours after meals (breakfast, lunch and dinner) for one day using an Accu-chek ® glucometer. CAVI was measured using a VaSera VS-1500® device (Fukuda Denshi), and baPWV was calculated using a validated equation.
RESULTS:
CAVI and baPWV values were significantly higher in subjects with diabetes mellitus than in glucose normal and prediabetes groups (p<0.001). FPG, PG and HbA1c were positively associated with CAVI and baPWV. The β regression coefficient for: HbA1c was 0.112 (CI 95% 0.068 to 0.155) with CAVI, 0.266 (CI 95% 0.172 to 0.359) with baPWV; for PG was 0.006 (CI 95% 0.004 to 0.009 and for FPG was 0.005 (CI 95% 0.002 to 0.008) with baPWV; and for PG was 0.002 (CI 95% 0.001 to 0.003) and 0.003 (CI 95% 0.002 to 0.004) with CAVI (p<0.01 in all cases). When analysing by hyperglycaemic status, FPG, PG and HbA1c were positively associated with CAVI and baPWV in subjects with type 2 diabetes mellitus.
CONCLUSION:
FPG, PG and HbA1c show a positive association with CAVI and baPWV, in Caucasian adults with intermediate cardiovascular risk factors. When analysing by hyperglycaemic status, the association is only maintained in subjects with type 2 diabetes mellitus
A multiple health behaviour change intervention to prevent depression: A randomized controlled trial
Objective: To examine the effectiveness of a 12-month MHBC intervention in the prevention of onset depression in primary health care (PHC). Methods: Twenty-two PHC centres took part in the clusterrandomized controlled trial. Patients were randomized to receive either usual care or an MHBC intervention. The endpoints were onset of major depression and reduction of depressive symptoms in participants without baseline depression at a 12-month follow-up. Results: 2531 patients agreed and were eligible to participate. At baseline, around 43% were smokers, 82% were non-adherent to the Mediterranean diet and 55% did not perform enough physical activity. The intervention group exhibited a greater positive change in two or more behaviours (OR 1.75 [95%CI: 1.17 to 2.62]; p = 0.006); any behaviour (OR 1.58 [95%CI: 1.13 to 2.20]; p = 0.007); and adherence to the Mediterranean diet (OR 1.94 [95%CI: 1.29 to 2.94]; p = 0.002), while this increase was not statistically significant for smoking and physical activity. The intervention was not effective in preventing major depression (OR 1.17; [95% CI 0.53 to 2.59)]; p = 0.690) or reducing depressive symptoms (Mean difference: 0.30; [95% CI -0.77 to 1.36]; p = 0.726) during follow-up. Conclusions: As compared to usual care, the MHBC intervention provided a non-significant reduction in the incidence of major depression
The effectiveness of a smartphone application on modifying the intakes of macro and micronutrients in primary care: a randomized controlled trial. The EVIDENT II Study
Background: This study evaluates the effectiveness of adding a diet smartphone application to standard counseling to modify dietary composition over the long term (12 months). Methods: A randomized, controlled, multicenter clinical trial was conducted involving the participation of 833 subjects from primary care clinics (415 to the intervention (counseling + application) group (IG) and 418 to the control (counseling) group (CG)). Both groups were counseled about a healthy diet and physical activity. For the 3-month intervention period, the IG was also trained to use a diet smartphone application that involved dietary self-monitoring and tailored feedback. Nutritional composition was estimated using a self-reported food frequency questionnaire. Results: An analysis of repeated measures revealed an interaction between the group and the percentages of carbohydrates (p = 0.031), fats (p = 0.015) and saturated fats (p = 0.035) consumed. Both groups decreased their energy intake (Kcal) at 12 months (IG: −114 (95% CI: −191 to −36); CG: −108 (95% CI: −184 to −31)). The IG reported a higher percentage intake of carbohydrates (1.1%; 95% CI: 0.1 to 2.0), and lower percentage intakes of fats (−1.0%; 95% CI: −1.9 to −0.1) and saturated fats (−0.4%; 95%CI: −0.8 to −0.1) when compared to the CG. Conclusions: Better results were achieved in terms of modifying usual diet composition from counseling and the diet smartphone application compared to counseling alone. This was evaluated by a self-reported questionnaire, which indicated an increased percentage intake of carbohydrates, and decreased percentage intakes of fats and saturated fatsSpanish Ministry of Science and Innovation (MICINN) and the Carlos
III Health Institute/European Regional Development Fund (ERDF) (FIS: PI13/00618, PI13/01526, PI13/00058,
PI13/01635, PI13/02528, PI12/01474; RETICS: RD12/0005, RD16/0007), Regional Health Management of Castilla
and León (GRS 1191/B/15, GRS 909/B/14, GRS 770/B/13) and the Infosalud Foundatio
Clinico-pathological characteristics and outcomes of patients with early-onset colorectal cancer
[Background]: The rising incidence of colorectal cancer (CRC) among young patients is alarming. We aim to characterize the clinico-pathological features and outcomes of patients with early-onset CRC (EOCRC).
[Methods]: We included all of the patients with pathologically confirmed diagnosis of CRC at Hospital Universitario La Paz from October 2016 to September 2020. EOCRC age cut-off was 50 years. All statistical analyses were carried out using SPSS v.25.
[Results]: A total of 1152 patients were diagnosed with CRC, fifty-nine (5,1%) of them were After a median follow-up of 24 months, 279 patients have died. Median overall survival (OS) was not reached in either group (p = 0,06). Three-year OS was 80% (95%CI: 73-87) and 67 (95%CI: 65-69) in the younger and older group, respectively. In patients with localized disease that underwent surgery or other antineoplastic treatment ( n = 856), 159 events for disease-free survival (DFS) were observed. Median DFS was
[Conclusions]: Patients with EOCRC are diagnosed at a more advanced stage and display distinct biological features (more prevalence of dMMR and WT tumors among others). Studies focusing on screening in this population and deeper molecular profiling are needed
- …